Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 98

    Paras Healthcare appoints Max Healthcare ex-GM Puneet Srivastava as Vice President

    Paras Healthcare appoints Max Healthcare ex-GM Puneet Srivastava as Vice President

    Farhat Nasim8 Aug 2019 9:00 AM IST
    Puneet Srivastava will lead the Sales and Marketing function at a group level. Prior to joining Paras Healthcare, Srivastava was associated with the...
    Tech Giant Google collaborates with Doctors to help recognise diseases

    Tech Giant Google collaborates with Doctors to help recognise diseases

    Farhat Nasim7 Aug 2019 9:45 AM IST
    A student Claudius said there were chances that people might be misled into believing that they have dangerous diseases and would be prone to the...
    Granules India arm wins USFDA approval for stimulant drug Amphetamine Sulfate tablets

    Granules India arm wins USFDA approval for stimulant drug Amphetamine Sulfate tablets

    Medical Dialogues Bureau7 Aug 2019 9:30 AM IST
    Amphetamine Sulfate tablets is a generic version of Arbor Pharmaceuticals LLC's Evekeo tablets in similar strength, it added.New Delhi: Drug firm...
    Fortis Healthcare reports profit of Rs 78 crore for June quarter

    Fortis Healthcare reports profit of Rs 78 crore for June quarter

    Farhat Nasim7 Aug 2019 9:16 AM IST
    Gross debt was reduced from Rs 1,657 crore in the first quarter of 2018-19 to Rs 1,388 crore in April-June 2019-20 reflecting a robust net debt to...
    Daiichi Sankyo CEO capped USD 37 billion recovery with AstraZeneca deal: Bloomberg

    Daiichi Sankyo CEO capped USD 37 billion recovery with AstraZeneca deal: Bloomberg

    Medical Dialogues Bureau7 Aug 2019 9:10 AM IST
    Daiichi Sankyo CEO, Nakayama decided the company needed a change, so he sold the Sun Pharmaceutical stake and shifted his focus to cancer drugs,...
    Novo Nordisk buys drug factory in North Carolina for assistance in manufacturing, packaging new diabetes drug

    Novo Nordisk buys drug factory in North Carolina for assistance in manufacturing, packaging new diabetes drug

    Medical Dialogues Bureau7 Aug 2019 9:05 AM IST
    The tablet version of Novo Nordisk diabetes drug, known as semaglutide, is an important growth prospect for the Danish drugmaker, which faces pressure...
    HCL Technologies and Oracle Health Sciences Collaborate to Accelerate MHealth in Clinical Trials

    HCL Technologies and Oracle Health Sciences Collaborate to Accelerate MHealth in Clinical Trials

    Medical Dialogues Bureau6 Aug 2019 4:37 PM IST
    HCL Technologies (HCL), a leading global technology company and a Platinum-Level member of Oracle Partner Network (OPN), and Oracle Health Sciences...
    Natco Pharma gets EIR from USFDA for Kothur facility

    Natco Pharma gets EIR from USFDA for Kothur facility

    Medical Dialogues Bureau6 Aug 2019 4:35 PM IST
    New Delhi: Drug firm Natco Pharma on Monday said it has received establishment inspection report (EIR) from the US health regulator for its Kothur...
    Ananth Narayanan joins Medlife as co-founder and CEO

    Ananth Narayanan joins Medlife as co-founder and CEO

    Medical Dialogues Bureau6 Aug 2019 4:34 PM IST
    New Delhi: Online health platform Medlife on Monday said former Myntra-Jabong CEO Ananth Narayanan has joined the company as its chief executive...
    Zydus Cadila completes phase III trial of Diabetes drug Lipaglyn in India

    Zydus Cadila completes phase III trial of Diabetes drug Lipaglyn in India

    Medical Dialogues Bureau5 Aug 2019 10:00 AM IST
    Saroglitazar Magnesium was launched in India during September 2013, under the brand name 'Lipaglyn', for the treatment of hypertriglyceridemia and...
    Lupin gets EIR from USFDA for Oral Dosage facility in Aurangabad

    Lupin gets EIR from USFDA for Oral Dosage facility in Aurangabad

    Medical Dialogues Bureau5 Aug 2019 9:45 AM IST
    Lupin Ltd's Aurangabad facility is involved in the manufacture of Oral Solid Dosage, Oral Liquid and Powder for Oral Suspension products for the US...
    Maharashtra to set up single-window system to grant clearances, address grievances for pharma firms

    Maharashtra to set up single-window system to grant clearances, address grievances for pharma firms

    Medical Dialogues Bureau5 Aug 2019 9:30 AM IST
    Food and Drug Administration (FDA) Minister Jaykumar Rawal recently held meetings with representatives of the Indian Drug Manufacturing Association to...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Top Pharmacy Courses That Rule the Industry

    Top Pharmacy Courses That Rule the Industry

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Google CEO Sundar Pichai calls for regulation of AI

    Google CEO Sundar Pichai calls for regulation of AI

    Desi AI based healthtech startup NIRAMAI raises Rs 42.6 Crore in Series A Funding

    Desi AI based healthtech startup NIRAMAI raises Rs 42.6 Crore in Series A Funding

    MEDICREA UNiD IB3D Patient-Matched interbody cages get USFDA clearance

    MEDICREA UNiD IB3D Patient-Matched interbody cages get USFDA clearance

    Supreme Court to hear PIL seeking direction to govt for banning unregulated medical devices

    Supreme Court to hear PIL seeking direction to govt for banning unregulated medical devices

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok